Racial Disparities in Access to Psychedelic Treatments and Inclusion in Research Trials
Psychiatric Annals December 1, 2022 Justin Morales, Erik Quan, Arslaan Arshed et al. 27 citations
Psychedelic-assisted therapy research is growing, but racial and ethnic minority groups remain underrepresented in clinical trials. This article traces the history of psychedelics and their recent resurgence, explains how psychedelic medicine has been racialized, and documents current inequities in the field. It proposes an antiracism framework to decolonize psychedelic research by dismantling White power structures and returning authority to Indigenous cultures. The authors argue that the psychedelic movement has a rare opportunity to improve inclusion and show how to achieve it.